scholarly journals Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease

2012 ◽  
Vol 172 (4) ◽  
pp. 312 ◽  
Author(s):  
Kathleen Stergiopoulos
Angiology ◽  
2002 ◽  
Vol 53 (2) ◽  
pp. 149-156 ◽  
Author(s):  
Hisataka Sasao ◽  
Akita Endo ◽  
Tohru Hasegawa ◽  
Yoshihiko Ichikawa ◽  
Ryosuke Noda ◽  
...  

2007 ◽  
Vol 71 (9) ◽  
pp. 1360-1365 ◽  
Author(s):  
Noriyuki Fujii ◽  
Ryuta Asano ◽  
Masatoshi Nagayama ◽  
Tetsuya Tobaru ◽  
Kazuhiko Misu ◽  
...  

Thrombosis ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Karl Mischke ◽  
Christian Knackstedt ◽  
Nikolaus Marx

Anticoagulation represents the mainstay of therapy for most patients with atrial fibrillation. Patients on oral anticoagulation often require concomitant antiplatelet therapy, mostly because of coronary artery disease. After coronary stent implantation, dual antiplatelet therapy is necessary. However, the combination of oral anticoagulation and antiplatelet therapy increases the bleeding risk. Risk scores such as the CHA2DS2-Vasc score and the HAS-BLED score help to identify both bleeding and stroke risk in individual patients. The guidelines of the European Society of Cardiology provide a rather detailed recommendation for patients on oral anticoagulation after coronary stent implantation. However, robust evidence is lacking for some of the recommendations, and especially for new oral anticoagulants and new antiplatelets few or no data are available. This review addresses some of the critical points of the guidelines and discusses potential advantages of new anticoagulants in patients with atrial fibrillation after stent implantation.


Sign in / Sign up

Export Citation Format

Share Document